Ujjwal Neogi

Passage of the HIV capsid cracks the nuclear pore

From periphery to center stage: 50 years of advancements in innate immunity

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds

Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence